Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

STANOZOLOL for Aplastic anaemia: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 7 adverse event reports in the FDA FAERS database where STANOZOLOL was used for Aplastic anaemia.

Most Reported Side Effects for STANOZOLOL

Side Effect Reports % Deaths Hosp.
Drug abuse 93 52.8% 28 54
Intentional product misuse 30 17.1% 10 25
Left ventricular hypertrophy 26 14.8% 13 13
Off label use 17 9.7% 2 11
Acute kidney injury 15 8.5% 0 15
Testicular atrophy 15 8.5% 10 4
Acute myocardial infarction 14 8.0% 0 12
Toxicity to various agents 14 8.0% 14 2
Hyperthyroidism 13 7.4% 0 13
Focal segmental glomerulosclerosis 12 6.8% 0 12
Drug-induced liver injury 11 6.3% 0 9
Hypertension 11 6.3% 4 11
Product use in unapproved indication 11 6.3% 0 10
Acute respiratory distress syndrome 10 5.7% 0 10
Chronic kidney disease 10 5.7% 0 10

Other Indications for STANOZOLOL

Product used for unknown indication (61) Muscle building therapy (25) Supplementation therapy (14) Performance enhancing product use (12) Drug abuse (11) Intentional product misuse (8)

Other Drugs Used for Aplastic anaemia

CYCLOSPORINE (1,668) ELTROMBOPAG OLAMINE (1,617) ELTROMBOPAG (1,121) LAPINE T-LYMPHOCYTE IMMUNE GLOBULIN (421) EQUINE THYMOCYTE IMMUNE GLOBULIN (293) DEFERASIROX (277) THYMOCYTE IMMUNE GLOBULIN NOS (249) ROMIPLOSTIM (231) CYCLOPHOSPHAMIDE (122) METHYLPREDNISOLONE (90)

Related Pages

STANOZOLOL Full Profile All Aplastic anaemia Drugs STANOZOLOL Demographics STANOZOLOL Timeline